Abstract: An example method for displaying clinical content includes monitoring user interaction with an image viewer displaying clinical content to a user according to a hanging protocol. The example method includes identifying a change in configuration of the hanging protocol and capturing, based on user input, criteria associated with the change. The example method includes saving the criteria in association with the hanging protocol and providing the saved hanging protocol and associated criteria for selection and application to clinical content to be displayed.

Abstract: A method is provided for joining a filler material to a substrate material. The method includes melting the filler material within a melting chamber of a crucible such that the filler material is molten. The crucible has an outlet fluidly connected to the melting chamber. The method also includes holding the filler material within the melting chamber of the crucible by applying a first pressure differential across the outlet of the crucible, and releasing the filler material from the melting chamber of the crucible by applying a second pressure differential across the outlet of the crucible to deliver the filler material to a target site of the substrate material. The second pressure differential has a different value than the first pressure differential.

Abstract: A method is provided for joining a filler material to a substrate material. The method includes melting the filler material within a melting chamber of a crucible such that the filler material is molten, holding the filler material within the melting chamber of the crucible by electromagnetically levitating the filler material within the melting chamber, and releasing the filler material from the melting chamber of the crucible to deliver the filler material to a target site of the substrate material.

Abstract: Disclosed herein are human monoclonal antibodies that specifically bind both IGF-I and IGF-II with picomolar affinity and potently inhibit the IGF-IR signal transduction function. These antibodies are active in both an IgG and a scFv format. Bispecific forms of these antibodies are also disclosed. Nucleic acids encoding these antibodies, vectors including these nucleic acids, and host cells transformed with these vectors are also disclosed herein. Also disclosed are pharmaceutical compositions including these antibodies. Methods are provided for treating a subject with cancer and for inhibiting phosphorylation of the insulin-like growth factor-I receptor. Methods are also provided for diagnosing cancer.

Abstract: Methods and systems for generating saliency models are discussed. Saliency models can be applied to visual scenes to generate predictions on which locations in the visual scenes are fixation locations and which locations are nonfixation locations. Saliency models are learned from fixation data on the visual scenes obtained from one or more subjects.

Abstract: A device detects and diagnoses correlated anomalies of a network. The device includes an anomaly detection module receiving a first data stream including an event-series related to the network. The anomaly detection module executes at least one algorithm to detect a potential anomaly in the event-series. The device further includes a correlating module receiving a second data stream including other event-series related to the network. The correlating module determines whether the potential anomaly is false and determines whether the potential anomaly is a true anomaly.

Abstract: The subject application relates to a method and system for power delivery network analysis. The present disclosure is directed towards a computer-implemented method for analyzing a power delivery network (PDN) associated with an electronic circuit design. Embodiments may include extracting, using at least one processor, an electromagnetic (EM) model for each of one or more discontinuity structures associated with the circuit design and generating a three dimensional adaptive mesh model that is based upon, at least in part, the extracted EM model. Numerous other features are also within the scope of the present disclosure.

Abstract: A system and method for detecting billing errors using predictive models is provided. The system includes a computer system and a billing error detection engine capable of detecting billing errors using predictive modeling techniques. The system receives and pre-processes billing information. The system then applies one or more predictive models to the information to identify billing errors. The results could be optionally sent to, and reviewed by, third party auditors, whereby their feedback could be incorporated into the results. A final report is generated by the system which indicates billing errors that require correction, thereby allowing an entity to correct such errors and prevent revenue leakage.

Abstract: Embodiments of the present invention disclose ceramic membranes having bonded ceramic nanowires. Methods of making ceramic membranes having bonded ceramic nanowires are also disclosed.

Abstract: The subject application relates to a method and system for power delivery network analysis. The present disclosure is directed towards a computer-implemented method for displaying one or more results of a power delivery network (PDN) analysis associated with an electronic circuit design. The method may include extracting, using at least one processor, an electromagnetic (EM) model for each of one or more discontinuity structures associated with the electronic circuit design. The method may further include performing a power delivery network analysis of the electronic circuit design, the PDN analysis including a Method of Moments (MoM) calculation. The method may also include displaying a three dimensional image depicting one or more results of the PDN analysis. Numerous other features are also within the scope of the present disclosure.

Abstract: A device detects and diagnoses correlated anomalies of a network. The device includes an anomaly detection module receiving a first data stream including an event-series related to the network. The anomaly detection module executes at least one algorithm to detect a potential anomaly in the event-series. The device further includes a correlating module receiving a second data stream including other event-series related to the network. The correlating module determines whether the potential anomaly is false and determines whether the potential anomaly is a true anomaly.

Abstract: A method for allocating vehicles to auction sites. An inventory database stores information uniquely identifying a plurality of items and associating each of the items with one of a plurality of available auction sites. Constraints relating to the movement of the items are stored in a constraints database. Items are identified which are available to be moved from a current location to one of the auction sites. A profit value is estimated for each available move. A move is identified for one item having a highest estimated profit above an identified threshold and meeting related constraints. This move is selected, and profits are reestimated for remaining items to be moved. The selection steps are repeated until no remaining available moves are feasible according to the threshold and constraints. Once all feasible moves have been selected, information associated with the items and moves is transmitted to a client device.

Abstract: An apparatus for segmenting a cerebral hemorrhage site in a medical image of a head comprises a means for segmenting an internal region of a skull bone in the medical image of the head, a means for segmenting a possible region in which a cerebral hemorrhage site is contained, out of the region segmented by the means for segmenting the internal region of the skull bone, and a means for determining a cerebral hemorrhage site out of the region segmented by the means for segmenting the possible region in which the cerebral hemorrhage site is contained.

Abstract: The present invention relates to compounds, compositions, methods, systems and kits for treating neuropathic pain regulated by SIP30. The present invention provides SIP30 antagonists for the treatment of neuropathic pain.

Abstract: The subject application relates to a method and system for power delivery network analysis. The present disclosure is directed towards a computer-implemented method for displaying one or more results of a power delivery network (PDN) analysis associated with an electronic circuit design. The method may include extracting, using at least one processor, an electromagnetic (EM) model for each of one or more discontinuity structures associated with the electronic circuit design. The method may further include performing a power delivery network analysis of the electronic circuit design, the PDN analysis including a Method of Moments (MoM) calculation. The method may also include displaying a three dimensional image depicting one or more results of the PDN analysis. Numerous other features are also within the scope of the present disclosure.

Abstract: The subject application relates to a method and system for power delivery network analysis. The present disclosure is directed towards a computer-implemented method for analyzing a power delivery network (PDN) associated with an electronic circuit design. Embodiments may include extracting, using at least one processor, an electromagnetic (EM) model for each of one or more discontinuity structures associated with the circuit design and generating a three dimensional adaptive mesh model that is based upon, at least in part, the extracted EM model. Numerous other features are also within the scope of the present disclosure.

Abstract: The subject application relates to a method and system for power delivery network analysis. The present disclosure is directed towards a computer-implemented method for analyzing a power delivery network (PDN) system. The method may include receiving at least one of a chip power model, a package power model and a board power model at the computing device and co-simulating at least two of the chip power model, the package power model, and the board power model. Numerous other features are also within the scope of the present disclosure.

Abstract: This invention relates to coating a surface wherein the coated surface inhibits foulants such as cell and/or protein and/or prion adhesion or formation. In particular, the coated surface may be part of a medical device which inhibits bacterial adhesion and colonisation, thrombus formation and/or prion, blood protein and/or protein formation.

Abstract: Systems and methods to model user activity information associated with a network system are provided. A particular method includes receiving, at a computing device, a request for user activity information associated with selected channels of a television access network that provides multimedia content to users. The method includes executing a model of user activity associated with the television access network at the computing device. The model estimates the user activity information as user multimedia access demands during particular time periods within a day. The method also includes storing the user activity information at a computer-readable non-transitory storage medium.

Abstract: Methods and systems for generating saliency models are discussed. Saliency models can be applied to visual scenes to generate predictions on which locations in the visual scenes are fixation locations and which locations are nonfixation locations. Saliency models are learned from fixation data on the visual scenes obtained from one or more subjects.